Home > Healthcare & Medical Devices > Thrombectomy Devices Market

Thrombectomy Devices Market Size By Product Type (Ultrasound-assisted Thrombectomy Devices, Rotational Thrombectomy Devices, Aspiration Thrombectomy Devices, Mechanical/Fragmentation Thrombectomy Devices, Clot Extraction Catheter, Stent Retrievers, Microcatheters), By Application (Peripheral Thrombectomy, Neurovascular Thrombectomy, Cardiovascular Thrombectomy), By End User (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI5245
  • Published Date: Apr 2022
  • Report Format: PDF

Industry Overview

Thrombectomy Devices Market size surpassed USD 1.2 billion in 2021 and is projected to register 6.8% CAGR between 2022 and 2028. Growing prevalence of cardiovascular disorders (CVD) is one of the major factors augmenting the high demand for thrombectomy devices industry.

Get more details on this report - Request Free Sample PDF

Moreover, diabetes mellitus, hypertension, excess weight, smoking, and unhealthy dietary habits are some of the primary risk factors leading to the development of numerous forms of cardiovascular diseases. For instance, according to the World Health Organization (WHO), cardiovascular disease is responsible for more than 17 million deaths annually, further accounting for an estimated 31% of the deaths across the world. Patients suffering from such chronic cardiac conditions may develop platelet aggregation/clotting which increases the risk of sudden heart failure or heart attack.

As thrombectomy is proven to be a highly effective procedure for the aspiration of these blood clots, the market is anticipated to witness considerable product demand with the growing disease burden.

Although the COVID-19 has disrupted several healthcare activities, the thrombectomy devices market continued to witness robust growth. The higher risk of thromboembolism among COVID-19 patients led to increased demand for thrombectomy procedures thereby boosting market revenue. Further, an increasing number of COVID-19 patients experiencing acute ischemic strokes (AIS) has resulted in a high mortality rate. This has driven the need for effective therapeutic interventions, thereby stimulating the market demand during the pandemic.

Thrombectomy devices are advanced products that are used for the removal of blood clots from veins and arteries. Numerous products such as aspiration thrombectomy devices, clot extraction catheters, microcatheters and stent retrievers are widely used for interventional procedures to remove thrombus from peripheral arteries, coronary arteries, and cerebral arteries.

Rising adoption of minimally invasive procedures worldwide will stimulate the market expansion during the forecast period

Growing preference for minimally invasive treatments coupled with technological advancements in thrombectomy devices is expected to significantly impact the market statistics. Thrombectomy procedure involves the insertion of devices such as catheters for removal or suppression of accumulated plaque to get rid of the blockage and thereby increase the diameter of blood vessels to facilitate proper blood flow. Such minimally invasive procedures result in a relatively lower risk of infections in comparison with an invasive procedure.

Moreover, a high preference for minimally invasive thrombectomy procedures due to enhanced patient outcomes will stimulate overall market demand. Furthermore, several benefits of thrombectomy devices such as improved treatment efficiency reducing pain during the procedure and allowing ease in complex operations will contribute to the overall market forecast.

Additionally, an increase in the usage of numerous analytical instruments including fluoroscopy or continuous x-ray which allow the physicians to extract the blood clot with better efficiency during the procedure. Thus, reduced recovery time, high patient outcomes and better results of minimally invasive surgeries will augment the overall market share.

Increasing adoption of minimally invasive procedures and the launch of innovative products will augment the product demand

Get more details on this report - Request Free Sample PDF

Thrombectomy devices market by product type is segmented into ultrasound-assisted thrombectomy devices, rotational thrombectomy devices, aspiration thrombectomy devices, mechanical/fragmentation thrombectomy devices, clot extraction catheters, stent retrievers, microcatheters, and others.

Mechanical/fragmentation thrombectomy devices segment held more than USD 390 million in revenue in 2021. The segment growth is highly attributable to the growing applications and enhanced effectivity of mechanical thrombectomy in disease treatment.

With increased preference leading to rising procedural volume, the industry is anticipated to witness escalating product demand. Furthermore, mechanical thrombectomy is proven to improve patient survival rate and reduces the risk of disability among patients suffering from a stroke. Thus, the aforementioned factors will influence the overall industry growth in the nearby future.

Increasing incidence rate of peripheral atrial diseases coupled with sedentary lifestyle will fuel demand for thrombectomy devices industry

Get more details on this report - Request Free Sample PDF

Thrombectomy devices market by application is segmented into peripheral thrombectomy, neurovascular thrombectomy and cardiovascular thrombectomy. Peripheral thrombectomy segment is anticipated to proceed at a CAGR of 7.2% during the estimated timeframe.

Thrombectomy provides effective treatment for peripheral diseases that helps to reduce the blockages in the blood vessels formed due to rising risk factors such as smoking and consumption of high cholesterol food. Increasing incidence rate of peripheral atrial diseases (PAD) is further fuelling the demand for thrombectomy devices.

Sophisticated infrastructure and skilled workforce will drive the demand for advanced thrombectomy devices in hospital settings

Thrombectomy devices market by end-user is segmented into hospitals, ambulatory surgical centers and others. The hospitals segment held a major market share of more than 54% in 2021. Developing sophisticated infrastructure and integration of advanced technology inbuilt instruments for numerous disease treatments are expected to boost the segmental demand.

Moreover, the strong presence of a skilled workforce and availability of catheterization laboratories within the hospital premises will further accelerate the market statistics. Furthermore, these settings offer numerous advantages such as large-scale operations, multi-functionality, and favorable reimbursement scenarios in some countries that will further positively influence the segmental expansion.

Growing burden of cardiovascular diseases and high healthcare expenditure will positively impact the North America thrombectomy devices market size

Get more details on this report - Request Free Sample PDF

North America thrombectomy devices industry was valued at more than USD 460 million in 2021. An increase in the geriatric population that are highly susceptible to several chronic disorders will accelerate the market demand in the region. Also, a large population base suffering from several CVDs puts a cost burden. Americans spend over USD 200 billion on CVDs each year. With growing costs, the need for effective treatment is also increasing, thereby offering innovation potential to the market players.

Additionally, growing awareness regarding vascular diseases among the population, an increase in healthcare expenditure, favourable reimbursement scenarios and government initiatives are propelling the regional market growth. Moreover, the availability of advanced technologies in healthcare facilities with a strong presence of leading innovation-oriented industry players will offer unprecedented market growth opportunities during the projection period.

New product development and acquisitions will offer lucrative growth opportunities to the market players

Major industry players involved in the thrombectomy devices market include Argon Medical, Johnson & Johnson, Penumbra Inc., Terumo Corporation, Edwards Lifesciences Corporation, LeMaitre Vascular Inc., Stryker Corporation, Boston Scientific Corporation, Teleflex Incorporated, and Medtronic among others. These market participants have incorporated several strategic initiatives such as partnerships, new product development and launches, collaborations, acquisitions, and others to enhance their business share and gain a competitive edge over other market player.

Some of the recent industry developments:

  • In September 2021, Boston Scientific Corporation announced the acquisition of Devoro Medical, Inc., with its WOLF thrombectomy platform. This platform target and detain blood clots by using finger-like prongs that are integrated with lytic-free WOLF technology. This will strengthen the company’s product portfolio in the thrombectomy devices market.
  • In September 2020, CERENOVUS, a part of Johnson & Johnson has launched CERENOVUS Stroke Solutions suit that includes CERENOVUS large-bore catheter, EMBOTRAP III revascularization device and CEREBASE DA guide sheath for blood clot management. This has broadened the company’s product offerings in the significant market thereby enhancing segment revenue growth.

Thrombectomy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

By Product Type

  • Ultrasound-assisted thrombectomy devices
  • Rotational thrombectomy devices
  • Aspiration thrombectomy devices
  • Mechanical/fragmentation thrombectomy devices
  • Clot extraction catheter
  • Stent retrievers
  • Microcatheters
  • Others

By Application

  • Peripheral thrombectomy
  • Neurovascular thrombectomy
  • Cardiovascular thrombectomy

By End-user

  • Hospitals
  • Ambulatory surgical centres
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE


Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

Global market for thrombectomy devices exceeded USD 1.2 billion in 2021 and is expected to grow at a CAGR of 6.8% from 2022 to 2028 owing to the rising prevalence of cardiovascular disorders.
Peripheral thrombectomy devices industry size is estimated to grow at a CAGR of 7.2% through 2028 driven by the rising incidence rate of peripheral atrial diseases.
North American market for thrombectomy devices crossed USD 460 million in 2021 and is projected to depict lucrative growth considering the rise in geriatric population.
Prominent players in the thrombectomy devices industry comprise Stryker Corporation, Terumo Corporation, Argon Medical, Teleflex Incorporated, Edwards Lifesciences Corporation, Boston Scientific Corporation, and others.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 209
  • Countries covered: 19
  • Pages: 157
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount